AXSOME THERAPEUTICS
Live / Applied — Third extension granted (statement of use) (as of 01 Dec 2025)
What this means for you
Not registered yet, but its 26 Jul 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98102355
- Mark type
- Stylized text
- Filed
- 26 Jul 2023
- Published for opposition
- 14 May 2024
- Attorney of record
- Brent Johnson
Goods and services
- Class 005 — Pharmaceuticals: house mark for medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, depression, diabetes, hypertension, skin disorders, allergies, asthma, obesity, and hair loss
Owner
- Axsome Therapeutics, Inc., New York, NY, US
- Axsome Therapeutics, Inc., New York, NY, US
Prosecution history
- 02 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Dec 2025 — SOU EXTENSION 3 GRANTED
- 01 Dec 2025 — SOU EXTENSION 3 FILED
- 01 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Sept 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Sept 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2025 — SOU EXTENSION 2 GRANTED
- 23 Jun 2025 — SOU EXTENSION 2 FILED
- 23 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 02 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED